John Glaspy was named the inaugural Simms/Mann Family Foundation Endowed Chair in Integrative Oncology at David Geffen School of Medicine at University of California, Los Angeles.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
